Fast and Robust Next-Generation Sequencing Technique Using Ion Torrent Personal Genome Machine for the Screening of Neurofibromatosis Type 1 (NF1) Gene

被引:20
作者
Balla, Bernadett [1 ,2 ]
Arvai, Kristof [2 ]
Horvath, Peter [1 ]
Tobias, Balint [1 ]
Takacs, Istvan [1 ]
Nagy, Zsolt [1 ]
Dank, Magdolna [1 ]
Fekete, Gyoergy [3 ]
Kosa, Janos P. [1 ,2 ]
Lakatos, Peter [1 ,2 ]
机构
[1] Semmelweis Univ, Dept Internal Med 1, H-1083 Budapest, Hungary
[2] PentaCore Lab, H-1028 Budapest, Hungary
[3] Semmelweis Univ, Dept Paediat 2, H-1094 Budapest, Hungary
关键词
Neurofibromatosis; Genetics; Next-generation sequencing; Ion Torrent;
D O I
10.1007/s12031-014-0286-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neurofibromatosis type 1 (NF1) gene exhibits one of the highest spontaneous mutation rates in the human genome. Identification of the NF1 mutation is challenging because the NF1 gene is very large and complex, lacking mutational "hot spots." There is no clustering of mutations, there are several pseudogenes, and a wide spectrum of different types of mutation has been recognized. To date, NF1 mutations or deleted regions have been detected with a number of techniques. With the appearance of next-generation sequencing (NGS) machines, molecular biology is in a new revolutionary phase. Our aim was to work out a method to use the high-throughput NGS machine, Ion Torrent PGM, in diagnostic settings for neurofibromatosis type 1. In our examination, we could reveal 21 distinct variations in NF1 gene in seven patients. This is an absolutely new method for exploring the genetic background of neurofibromatosis type 1 exhibiting the extremely high throughput of NGS in a diagnostic setting.
引用
收藏
页码:204 / 210
页数:7
相关论文
共 16 条
[1]   Forensic considerations in cases of neurofibromatosis - An overview [J].
Byard, Roger W. .
JOURNAL OF FORENSIC SCIENCES, 2007, 52 (05) :1164-1170
[2]   Platelet-derived Growth Factor-BB Activates Calcium/Calmodulin-dependent and -independent Mechanisms That Mediate Akt Phosphorylation in the Neurofibromin-deficient Human Schwann Cell Line ST88-14 [J].
Farrer, Robert G. ;
Farrer, Jason R. ;
DeVries, George H. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (16) :11066-11073
[3]   A high-throughput nonisotopic protein truncation test [J].
Gite, S ;
Lim, M ;
Carlson, R ;
Olejnik, J ;
Zehnbauer, B ;
Rothschild, K .
NATURE BIOTECHNOLOGY, 2003, 21 (02) :194-197
[4]   Evaluation of denaturing high performance liquid chromatography (DHPLC) for the mutational analysis of the neurofibromatosis type 1 (NF1) gene [J].
Han, S ;
Cooper, DN ;
Upadhyaya, M .
HUMAN GENETICS, 2001, 109 (05) :487-497
[5]   MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors [J].
Jessen, Walter J. ;
Miller, Shyra J. ;
Jousma, Edwin ;
Wu, Jianqiang ;
Rizvi, Tilat A. ;
Brundage, Meghan E. ;
Eaves, David ;
Widemann, Brigitte ;
Kim, Mi-Ok ;
Dombi, Eva ;
Sabo, Jessica ;
Dudley, Atira Hardiman ;
Niwa-Kawakita, Michiko ;
Page, Grier P. ;
Giovannini, Marco ;
Aronow, Bruce J. ;
Cripe, Timothy P. ;
Ratner, Nancy .
JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (01) :340-347
[6]   The Pathoetiology of Neurofibromatosis 1 [J].
Jouhilahti, Eeva-Mari ;
Peltonen, Sirkku ;
Heape, Anthony M. ;
Peltonen, Juha .
AMERICAN JOURNAL OF PATHOLOGY, 2011, 178 (05) :1932-1939
[7]   Mosaicism in sporadic neurofibromatosis type 1: variations on a theme common to other hereditary cancer syndromes? [J].
Kehrer-Sawatzki, H. ;
Cooper, D. N. .
JOURNAL OF MEDICAL GENETICS, 2008, 45 (10) :622-631
[8]   Mutation Spectrum of NF1 and Clinical Characteristics in 78 Korean Patients With Neurofibromatosis Type 1 [J].
Ko, Jung Min ;
Sohn, Young Bae ;
Jeong, Seon Yong ;
Kim, Hyon-Ju ;
Messiaen, Ludwine M. .
PEDIATRIC NEUROLOGY, 2013, 48 (06) :447-453
[9]   Recent developments in neurofibromatosis type 1 [J].
Lee, Ming-Jen ;
Stephenson, Dennis A. .
CURRENT OPINION IN NEUROLOGY, 2007, 20 (02) :135-141
[10]   Effective neurofibromatosis therapeutics blocking the oncogenic kinase PAK1 [J].
Maruta, Hiroshi .
DRUG DISCOVERIES AND THERAPEUTICS, 2011, 5 (06) :266-278